Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Eur J Cardiothorac Surg. 2010 Feb 12;37(6):1421–1426. doi: 10.1016/j.ejcts.2010.01.010

TABLE 1.

Demographic and Clinical Characteristics and Pathologic Staging.


N = 37
Age (years), mean ± SD (range) 65 ± 8.7 (42 to 85)

Sex, M:F 32:5

Tumor histology, n (%)

 Adenocarcinoma 29 (78%)

 Squamous Cell Carcinoma 5 (14%)

 High Grade Dysplasia in Barrett Esophagus 3 (8%)

Tumor Location, n (%)

 Distal Esophagus, GE Junction 34 (92%)

 Mid Thoracic Esophagus 3 (8%)

Neo-adjuvant treatment, n (%)

 Radiation only 3 (8%)

 Chemotherapy only 2 (5%)

 Chemotherapy and Radiation 15 (41%)

Pathological Stage AJCC Classification

 High Grade Dysplasia in Barrett Esophagus 3 (8.1%)

 0 4 (10.8%)

 I 3 (8.1%)

 II 14 (37.8%)

 III 12 (32.4%)

 IV 1 (2.7%)